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Abstract 
 
Dual-Axial Blood Pump Mechanical Circulatory 
Support for Fontan Patients 
 
Shravani Birewar 
 
 
 
 
The current treatment paradigm for patients with dysfunctional or failing 
single ventricle physiology involves pharmacologic therapy, surgical 
reconstruction of the Fontan physiology, and heart transplantation. The limited 
number of donor hearts and complication of a Fontan surgical takedown require 
alternative treatment strategies for these patients. Existing mechanical circulatory 
support systems are inadequate for these patients since these devices were 
designed for the systemic circulation in patients with a biventricular circulation, 
not a Fontan physiology. Therefore, researchers have been developing new 
blood pumps for single ventricle patients. As a new therapeutic approach, this 
thesis considers a newly combined configuration of dual-axial flow blood pumps 
located in the pulmonary arteries to mechanically support the Fontan physiology. 
The initial design geometries were constructed using computer-aided design 
software. Pump design equations and empirical data were utilized to create the 
differing design configurations based on pump placement, diameter, protective 
cage filaments, stagger angle, blade number, and operational states. The pump 
performance of these configurations was assessed using robust ANSYS CFX 
turbomachinery software. Over 150 simulations were performed over a range of 
blood flow rates and rotational speeds. Pressure rise, energy augmentation, and 
x 
 
 
blood damage indices were determined for the pump geometries considered. All 
simulations showed pressure and energy augmentations within and above the 
needed range for improved cavopulmonary conditions. Additionally, all 
simulations examined for blood trauma showed mean blood damage indices 
below 1%. Overall, the current research was successful and demonstrated 
significant proof-of-concept support in the development of a dual-support 
approach for patients having dysfunctional or failing Fontan physiology.  
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1. Motivation and Significance 
 
 
 
1.1 Motivation and Significance 
 
 
Globally, two million children are born with a congenital heart defect every 
year [1]. Cardiovascular defects are attributed to 6-10% of all infant deaths. 
Without surgical or therapeutic intervention, a patient with significant cardiac 
malformations, such as those with severe defects or only a single functioning 
ventricle, would rapidly decompensate to congestive heart failure (CHF), 
resulting in death within two weeks after birth [2]. Patients with single ventricle 
physiology require long-term intensive management, monitoring, and therapy to 
slow the inevitable decline to CHF. The clinical treatment and management of 
patients having congenital heart defects costs approximately $1.4 billion per 
year, while the incidence of single ventricle physiology occurs 1 in 2000 births 
per year [3, 4]. 
 
 
1.1.1 Normal Physiology 
 
 
In contrast to a single ventricle physiology and for distinguishing purposes, 
a healthy heart is divided into four chambers: the left and right ventricles and the 
left and right atria (Figure 1). The left and right atria receive blood from the 
pulmonary and systemic circulations, respectively. The pulmonary veins lead to 
the left atrium, and the superior and inferior vena cavae (SVC and IVC) lead to 
the right atrium. The blood then passes through valves to enter into the 
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ventricles. The ventricles act as pumps to generate the necessary pressure for 
blood to travel into the systemic and pulmonary circuits. The right ventricle 
pushes blood into the left and right pulmonary (LPA and RPA) arteries that lead 
to the lungs, and the left ventricle pushes blood into the aorta, which branches to 
supply blood to the rest of the body. 
 
 
 
 
Figure 1: Diagram of the normal physiology of a human heart and blood flow [5]. 
 
 
 
 
1.1.2 Single Ventricle and the Fontan Procedure 
 
 
Contrary to a normal physiology, a single ventricle or Fontan physiology 
consists of only one functional ventricle to both drive and draw blood through the 
systemic and pulmonary circulations. In order to achieve the Fontan physiology, 
patients must undergo 3 or more open-heart, staged surgeries as discussed in 
the following paragraphs.  
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The open-heart procedures are called the Norwood procedure, the Glenn 
(or Hemi-Fontan), and the Fontan completion. The Norwood procedure occurs at 
two weeks of age, where an artery-to-pulmonary-artery shunt is created to allow 
blood flow to the lungs. The second procedure (the Glenn) involves making a 
connection between the superior vena cava and the pulmonary arteries and 
removing the Norwood shunt. This procedure is done at age 6 weeks. The final 
procedure, performed at the age of 3-5 years, is the Fontan procedure, which 
connects the inferior vena cava to the pulmonary arteries. This culminates in the 
final Fontan physiology that has a new vessel configuration that is called the total 
cavopulmonary connection (TCPC), where the inferior and superior vena cavae 
connect directly to the pulmonary arteries (as seen in Figure 2). This results in 
deoxygenated blood flowing directly to the pulmonary circuit rather than entering 
the right atrium to be pumped through the heart [2]. 
The TCPC physiology has cardiovascular benefits. It reduces the burden 
on the functioning ventricle by reducing the volume overload on the ventricle, and 
it normalizes arterial saturation. Moreover, it uses the energy from the capillaries 
to push the blood through the pulmonary system [6]. Additional surgical 
improvements have resulted in better blood flow and minimized scarring [1]. 
Overall, the Fontan physiology improves the life expectancy of the patients; 
however, long-term consequences of this 'human-made' physiology exist, and 
there are extremely few medical devices or therapeutic options beyond the early 
staged surgical procedures. 
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Figure 2: Diagram of the extracardiac TCPC configuration with a side comparison 
of normal heart vasculature [7]. 
 
 
 
 
1.1.3 Concerns of the TCPC 
 
 
Although the improvements from this procedure are realized in the short-
term, the patients still encounter physical and functional limitations associated 
with normal daily activities. Fontan patients have abnormal cardiovascular 
hemodynamics, increased systemic venous pressure, supraventricular 
arrhythmias, and reduced exercise capacity [2]. Fontan patients also have 
displayed the inability to increase stroke volume during exercise due to a 
decrease in end-diastolic volume [8]. Additionally, 15% of Fontan patients have 
protein-losing enteropathy. These symptoms result in a general decline to 
premature CHF, as seen in more than 40% of patients with a TCPC [9]. 
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A number of surgical interventions exist to assist with complications of the 
Fontan physiology, but these approaches only slow the progression of CHF. 
Interventions include reinclusion of previously excluded hepatic veins, baffle 
fenestration, atrioventricular valve repairs or replacements, pacemaker 
insertions, revisions to a lateral tunnel or an extra-cardiac Fontan, and a number 
of simple repair procedures. However, in the case of ventricular dysfunction or a 
failing Fontan circulation, cardiac transplantation is currently the only therapeutic 
option for the patients. Though there are a number of surgical interventions, 
cardiac transplantation is often a necessity for Fontan patients, which is 
challenging [10]. Apart from the long wait associated with waiting for a donor 
organ, Fontan patients are faced with a greater early mortality rate in comparison 
to non-Fontan patients with congenital heart disease or with cardiomyopathy [9, 
10]. The reconstruction of the systemic and pulmonary veins and the pulmonary 
arteries also make the transplant surgery a significant challenge [10]. In fact, the 
statistics demonstrate a 44% operative mortality rate for cardiac transplantations 
[2]. With these challenges, it is necessary to have new therapeutic solutions 
using innovative devices. Researchers and clinicians have hypothesized that an 
increase in pressure of 1 - 5mmHg in the Fontan circulation will produce 
improved physiological conditions for single ventricle patients [1]. To address this 
unmet therapeutic need, the BioCirc Laboratory at Drexel University is 
developing a novel intravascular blood pump to provide mechanical circulatory 
support of the cavopulmonary circulation in Fontan patients. Our long-term 
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objective is to provide a viable bridge-to-transplant therapeutic option for these 
Fontan patients.  
 
 
1.2 Existing Mechanical Assist Devices 
 
 
In addition to the development effort in our research laboratory, there are 
currently mechanical circulatory support systems that are being used for Fontan 
patients and several researchers are designing new devices to mechanically 
support the dysfunctional or failing single ventricle physiology. The following 
sections detail the existing technology being used for Fontan patients and the 
new technology that is under development.  
 
 
1.2.1 Extracorporeal Membrane Oxygenation 
 
 
Extracorporeal membrane oxygenation (ECMO) is often utilized to support 
patients with congenital or other forms of heart disease. Morbidity and mortality 
with ECMO support is very high, ranging from 33% to 60%. Although cases of 
ECMO support for Fontan patients exist, not many studies provide a strong 
understanding of its capabilities [11]. Rood et al. [11] analyzed ECMO utilization 
for cardiac failure after Fontan operation. Only 35% of patients survived hospital 
discharge. Causes of mortality included surgical bleeding, renal failure, and 
neurologic complications. On the other hand, 47% survival was reported for 
pediatric cardiac patients who received ECMO support. This clinical data 
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demonstrates the ongoing challenges associated with ECMO utilization for 
Fontan patients. 
 
 
1.2.2 Ventricular Assist Devices 
 
 
In contrast to ECMO, alternative medical devices that are used to support 
CHF patients are ventricular assist devices (VADs). VADs can support the left or 
right ventricles of the heart [12]. There are currently various types of VADs on the 
market. VADs can have pulsatile or continuous flow, which can have either a 
centrifugal or axial design. Additionally, VADs can be defined by the location of 
the pumps: intracorporeal, paracorporeal, and extracorporeal [13].  
A frequently used VAD, named Berlin Heart EXCOR, is often employed as 
a bridge-to-transplant device for pediatric and adult patients. A study was done 
with 48 children to evaluate EXCOR performance. The results showed that 
EXCOR was successful for 88% of the patients as a bridge-to-transplant or 
bridge-to-recovery therapeutic. The median duration for support was 28 days 
[13]. Additionally, a study conducted by Weinstein et al. [14] with twenty-six 
patients demonstrated that EXCOR can be used over a long duration for patients 
with single ventricle physiology as a bridge to cardiac transplantation. However, 
the overall success rate of utilizing EXCOR for single ventricle patients was 42%. 
Additionally, studies have shown adverse effects like infection, stroke, and 
bleeding post-implantation of the device [13]. Other challenges of the Berlin 
Heart EXCOR include mobility. Patients implanted with this device have limited 
mobility. A small and portable driving system exists for the biventricular 
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configuration. However the battery life of the driver is limited to five hours. 
Additionally, this device is limited to adult patients. Pediatric patients are confined 
to the Ikus drive system, a 93kg drive unit [12]. 
One of the major limitations with the current VADs on the market is that 
these devices are designed for supporting the systemic circulation and 
biventricular support rather than single ventricle support and a physiology with a 
TCPC. Thus, these devices produce significantly higher pressures than desired 
for the Fontan physiology [15]. For example, Jarvik 2000, by Jarvik Heart Inc., is 
an axial flow left VAD. Although, the design is able to support right ventricles by 
reducing the rotational speeds (6000-10000 RPM) to provide the needed 
pulmonary pressures, the design has not been changed to be able to support the 
right ventricle [12]. 
 
 
1.2.3 Cavopulmonary Support Devices 
 
 
No cavopulmonary assist devices (CPAD) currently exist for clinical use. 
However, several research labs are in the process of developing these devices 
or testing existing devices to serve as cavopulmonary support.  
Lacour-Gayet et al. [16] developed an artificial right ventricle design. This 
new model was developed with a conduit connecting the SVC and IVC. The 
conduit then forms a pathway (where an axial pump is placed) to the LPA and 
RPA. Although this design showed improvement in circulatory function within in 
vitro studies, its major drawback is that it requires complete reconstruction of the 
Fontan physiology. 
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Medvitz et al. [17] developed an extracardiac implant for full circulatory 
support. This design involved a Tesla design pump that utilized closely spaced 
parallel plates rather than impeller blades. Although this design showed positive 
hydrodynamic performance, it requires an invasive surgical procedure and is not 
designed for a Fontan physiology. The device is also significantly obstructive and 
could result in patient death if the pump fails or stops due to thrombus formation 
or mechanical failure. Similarly, Wang et al. [18] discussed an extracardiac 
concept, which combines their previously designed double lumen cannula (DLC) 
and a commercially available blood pump (CentriMag) as a cavopulmonary assist 
device. Based on this design, the DLC withdraws blood from the SVC and IVC 
and pumps the blood through a bridge graft into the RPA. 
Less invasive solutions have also been proposed by various researchers. 
Wang et al. [19] developed model with a DLC placed in the TCPC with two 
collapsible membrane umbrellas and a pump in the SVC. While the pump 
supports circulation, the umbrellas increase efficiency of the pump by preventing 
backflows. A temporary cavopulmonary support device by Giridharan et al. [20] 
involves an expandable viscous impeller pump with an expandable nitinol cage, 
and is located in the TCPC junction. The pump can be inserted percutaneously. 
Researchers showed a 23% increase in cardiac output in mock circulatory 
system experiments with this design. Axial blood pumps are also being 
researched and have shown promising results as cavopulmonary support 
devices. Wang et al. [21] developed a microaxial flow pump for placement in the 
IVC that has shown some success in computational and in vitro studies. Also, 
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Rodefeld et al. [22] implanted the Hemopump, an axial flow pump, in both vena 
cavae in yearling sheep that had undergone surgery to develop a total 
cavopulmonary diversion. This study demonstrated the application of 
nonpulsatile axial flow pumps to provide cavopulmonary support, thus showing 
the prospective benefits of CPAD devices. 
 
 
1.2.4 Limitations of Devices Under Development 
 
 
Even though devices are under development to support Fontan patients, 
there are many limitations of these pump designs. Table 1 highlights those 
limitations. Many of these devices discussed require invasive surgeries or have 
the risk of causing obstruction in the blood vessels. Additionally, blood 
stagnation, high shear stresses and blood damage can also result from some 
designs. Thus, a mechanical circulatory support is needed that can address 
these limitations in Table 1. 
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Table 1: Cavopulmonary support devices currently under development and their 
limitations 
Device Limitations 
Artificial Right Ventricle 
with Extracardiac Conduit 
 Requires reconstruction of Fontan 
Extracardiac Device with 
Tesla pump 
 Requires invasive surgery 
 Not designed for Fontan physiology 
 Severely obstructive if device fails 
DLC and CentriMag 
 Does not provide bidirectional lung perfusion 
 Requires invasive surgery 
DLC, Pump, and 
Collapsible Umbrellas 
 Blood stagnation at umbrellas can lead to 
thrombosis 
Expandable Viscous 
Impeller Pump 
 Failure can result in obstruction of TCPC 
 Patient must have cross-like vessel 
configuration 
Microaxial Flow Pump  Retrograde flow into SVC 
Hemopump 
 Can result in high blood damage and backflow 
into SVC 
  
 
 
 
1.3 New Solution: Dual-Axial Device Combination 
 
 
To address the limitations of existing devices and the clinical need for an 
implantable mechanical circulatory support in the cavopulmonary circulation of 
Fontan patients and to advance the current state-of-the-art in mechanical 
circulatory assistance, a unique design is under development in the BioCirc 
Research Laboratory at Drexel University. 
The BioCirc Research Laboratory has performed a significant amount of 
research to evaluate axial continuous flow pump performance in the TCPC and 
address the issues with Fontan physiology discussed. An axial flow pump design 
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has been shown to be successful through hydraulic and hemolysis testing at the 
BioCirc Lab. The desired hydraulic energy was generated, shear stresses were 
below 425 Pa, and the normalized index of hemolysis (N.I.H.) levels met design 
objectives [23]. 
The pump placement in the IVC has also been extensively evaluated. This 
placement has shown success in terms of pressure and energy augmentation 
[24]. However, due to the increased pressure generation and a greater IVC flow 
rate and pressure than SVC flow rate and pressure (due to the 60%/40% 
IVC/SVC split), retrograde flow into the SVC can result with higher rotational 
speeds. Additionally, in a normal physiology, the IVC blood carries liver factors 
that are crucial for lung function and development. It is necessary that the IVC 
blood flows into both the left and right pulmonary arteries to the lungs [25]. When 
the pump is placed in the IVC, the anatomical geometry of the TCPC shunts 
more IVC blood toward the RPA. However, research has shown that an even 
distribution of flow can be accomplished with reduced blood vorticity of IVC blood 
when entering the TCPC. This was achieved by placement of the pump below 
the hepatic flow connection in the IVC [24]. 
A dual-pump support has also been evaluated by placement of axial flow 
pumps in the SVC and the IVC. This prospective design showed positive results 
in pressure augmentation and hydraulic energy generation in computational 
analysis using the anatomical TCPC model. It also demonstrated low scalar 
stresses and residence times. However, blood damage results were higher than 
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the 2% criteria. Overall, this study showed that dual-pump designs can be utilized 
and can show positive results but require optimization [9]. 
The addition of a cage supporting the axial pump has also been studied. A 
cage is required for pump support and vessel wall protection. Studies showed 
that varying twists of the cage filaments can boost energy transfer generated by 
the impeller and reduce blood damage when compared to straight filaments [26, 
27]. 
Many studies done in the past have analyzed pump performance in an 
anatomical TCPC model. This was achieved by converting 2-D MRI images to 3-
D CAD models. It has been experimentally shown that the axial flow blood pump 
design is a viable therapeutic option in the anatomical TCPC [25]. 
To ameliorate the likelihood of retrograde blood flow into the SVC toward 
the brain, we are considering a new design. This novel design consists of a 
combination of a catheter, stent, and two axial pumps for dual mechanical 
support of the right and left pulmonary arteries. The catheter is T-shaped and 
allows for implantation of the two axial pumps. The stent in the design connects 
the SVC and IVC in the TCPC to direct blood flow for collection at the pump 
inlets. The axial pumps are placed into the left and right pulmonary arteries. The 
rotational action of the axial pumps propels the blood gathered from the stent into 
the pulmonary arteries. The overall goal of this configuration is to provide the 
amount of pressure needed for Fontan patients to have near-normal circulation 
as a bridge-to-transplant support system. The performance of this configuration 
will be simulated using computational fluid dynamic simulations. 
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This thesis is a proof-of-concept for this unique design developed in the 
BioCirc Research Laboratory. The design, seen below, incorporates successful 
aspects of the pump devices previously developed in the lab and seeks to 
overcome some of their design limitations. 
The model geometry was developed using SolidWorks 2014 and can be 
seen below in Figure 3. As discussed, BioCirc Laboratory has examined pump 
performance in patient-specific TCPC models. However, for the purpose of the 
initial evaluation of this novel design, the mechanical assist device was modeled 
within an idealized TCPC. The SVC and IVC (20mm diameters) and pulmonary 
arteries (25mm diameters) were modeled with ideal cylindrical structures. The 
vena cavae and pulmonary arteries intersect perpendicularly in this model.  
 
 
 
 
Figure 3: Conceptual design of the double axial blood pump and stent 
configuration. LPA: left pulmonary artery; RPA: right pulmonary artery; SVC: 
superior vena cava; IVC: inferior vena cava 
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The lumen stent in the design connects the SVC and IVC. This stent 
narrows in the center to allow for blood flow between the LPA and RPA, and also 
allows for blood collection from SVC and IVC. The stent was created using the 
lofting tool in SolidWorks, with the central inner diameter as approximately 10.86 
mm. Additionally, the stent consists of two circular openings on the lateral and 
medial sides through which the blood exits to reach the axial pumps. 
As discussed previously, continuous axial flow pumps designed in the 
BioCirc Laboratory have been shown to be effective in generating pressure and 
hydraulic energy, while minimizing blood damage and shear stresses. Thus, 
these axial pumps were utilized for the purpose of this design. The pumps have 
helically wrapped blades around the central hub. The angled blades extend with 
a width of 16.15 mm and the pumps have lengths of 30.5 mm. The two axial 
pumps are located in the LPA and RPA. This is in contrast to the previous 
studies conducted with a singular pump positioned in the IVC or dual pumps 
located in the IVC and SVC. The positioning in the pulmonary arteries and dual 
pump configuration serves to overcome the few design limitations discussed with 
the previous designs. This pump placement eliminates the risk of SVC backflow 
with increasing rotational speed. Instead, the pumps would generate suction 
pressure in the vena cavae, further encouraging blood collection in the stent. 
Additionally, this placement would eliminate vorticity in the IVC, thus allowing 
equal IVC and SVC blood flow into both arteries. Both pumps would then propel 
equal amounts of blood flow to each lung. Therefore, both lungs receive equal 
levels of liver factors. 
16 
 
 
 
The final aspect of the design is the catheter that will be utilized to 
percutaneously insert the pumps. The catheter has a 3.05 mm outer diameter. It 
is located in the SVC and branches in the stent to exit through its two openings 
and attaches to the pumps.  
In summary, this configuration would collect blood from the SVC and IVC 
and generate hydraulic energy to drive the blood through the pulmonary arteries. 
The axial pumps can create a suction effect to pull the blood from the stent and 
generate hydraulic energy to increase blood flow and reduce fluid congestion in 
the pulmonary arteries due to hypotension. This, in turn, would result in an 
increase in cardiac output and systemic blood flow. Overall, this design serves 
the functions of the right atrium and ventricle and seeks to resolve the long-term 
problems associated with the Fontan. 
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2. Design 
 
 
 
2.1 Problem Statement 
 
 
Thousands of Fontan patients have a dysfunctional single ventricle 
physiology. Although the Fontan procedure is the preferred surgical intervention 
for congenital heart defects with single ventricles, various issues are associated 
with the Fontan circulation. Due to the TCPC physiology, no subpulmonary 
power source or right ventricle exist to drive blood into the pulmonary arteries. 
Additionally, as the blood from the SVC and IVC meet at the TCPC, mixing 
results in turbulent flow and energy losses as the blood enters the pulmonary 
arteries. Symptoms of the Fontan physiology, such as abnormal cardiovascular 
hemodynamics, increased systemic venous pressure, supraventricular 
arrhythmias, and protein-losing enteropathy have resulted in premature heart 
failure in many Fontan patients [2]. Lack of therapeutic solutions, complications 
associated with cardiac transplantation, and high treatment costs despite the low 
number of patients have led to a critical need for mechanical pump solutions for 
Fontan patients. 
 
 
2.2 Thesis Project Objectives 
 
 
This project focuses on the proof-of-concept of a novel design approach. 
The overall goal of this thesis is to develop a new mechanical circulatory support 
configuration at the total cavopulmonary connection (TCPC) that is able to 
18 
 
 
 
improve physiological conditions for a Fontan patient suffering from dysfunctional 
single ventricle physiology. Detailed below are the four specific objectives of this 
project:  
 
1. Design a new dual-support configuration having a venous return 
collection stent in the TCPC of a Fontan physiology with mechanical 
circulatory assistance in the pulmonary arteries.  
The goal is to design a system that serves the purpose of the right atrium 
and ventricle of the heart. Thus, the design must appropriately allow for the 
collection of blood from the SVC and IVC at the TCPC and be directed to 
mechanical pumps. The pumps must be able to propel the blood through the 
pulmonary arteries. 
 
2. Develop and optimize the pump geometries, and determine inflow 
conditions, blood parameters, and design factors. 
In this objective, the configuration is designed by defining a number of 
parameters. The geometries and dimensions of the axial pumps and stent are 
determined, while considering the size constraints due to the dimensions of the 
TCPC. Additionally, the inflow conditions and blood parameters are selected to 
closely represent physiological conditions in the TCPC. A number of design 
factors are chosen to analyze their effect on pump performance. 
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3. Determine the shear stresses, pressure generation, energy gain, 
and blood damage indices in consideration of biophysical factors. 
A number of factors must be evaluated to understand the efficiency of the 
design. Firstly, pressure and hydraulic energy generations are needed to 
augment flow through the pulmonary arteries. Additionally, shear stresses must 
be evaluated for prevention of blood trauma. Blood damage index must also be 
calculated to ensure minimal hemolysis due to the design. The analysis of these 
values will help to determine whether the design factors chosen in Objective 2 
play a significant role in the pump performance. 
 
4. Determine optimal ranges of design factors to analyze their 
contribution to pump performance and confirm the feasibility of the design.  
By determining the ranges of the design factors that meet the necessary 
requirements in Objective 3, a conclusion can be made on whether the design 
can meet the necessary expectations needed for Fontan patients. As mentioned, 
the overall goal of this design is to improve the quality of living for Fontan 
patients by improving the physiological conditions in their circulatory system. This 
specific objective seeks to ensure that the axial pumps accomplish this goal 
through the implementation of necessary enhancements based on the analysis 
from Objective 3. 
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2.3 Design Requirements - General 
 
 
There are a number of constraints and requirements that must be met to 
develop a design that meets the patient needs and address the current 
limitations in the existing mechanical assist devices. First of all, the device must 
be made of biocompatible material and must be non-thrombogenic. Additionally, 
device implantation must be a minimally invasive process to diminish surgical 
and post-surgical complications and allow for a shorter recovery period. The 
device should also have an operative lifespan sufficiently larger than the current 
wait time periods of Fontan patients for heart transplants. Also, the device should 
be cost-effective. 
Regarding the device structure, the lumen stent should allow blood to be 
collected from the IVC and SVC but should not restrict flow between the LPA and 
RPA. The stent must have two outlets, and must be able to direct blood in both 
directions (into the LPA and RPA). The openings of the stent that lead to the 
pumps should not be so small to result in a significant pressure buildup in the 
stent. It is also important to ensure that the pump blades do not contact the blood 
vessel while the patient is still or in motion. Blades contacting the vessel while 
the impeller is in motion could damage and rupture the blood vessel. Lastly, the 
pump must be large enough to tolerate and propel the blood, with consideration 
of its mechanical properties (viscosity, density, flow rate, etc.). 
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2.4 Engineering Standards to Inform Design 
 
 
Table 2 includes a list of standards reviewed for their level of applicability 
to the current project. Three ASTM standards were assessed to determine 
whether they can be employed for this thesis or for future studies. 
ASTM F1841-97 standardizes hemolysis testing for continuous flow blood 
pumps. Hemolysis testing can help determine the level of blood trauma caused 
by the continuous flow blood pump design. However, it does not involve any 
aspects of computational modeling, thus this standard would be a necessity in 
the future when the design is experimentally tested in vitro. ASTM F1830-97 
standardizes the selection of blood for the standardized hemolysis testing 
method. Thus, this would also be a required standard in the future when the 
design is tested in vitro. Lastly, ASTM F2514-08 standardizes finite element 
modeling for a metallic stent. The standard is not entirely applicable to the 
current project as it is meant for another device. However, it includes software 
requirements, standards in developing the mesh, and additional steps that must 
be taken to validate and verify the analysis. These aspects of the standard can 
be referred to for the models that will be developed for the design. 
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Table 2: List of ASTM standards that can be applied to the evaluation of the 
device. 
Standard Title 
ASTM: F1841 − 97 
Standard Practice for Assessment of Hemolysis in 
Continuous Flow Blood Pumps 
ASTM: F1830 − 97 
Standard Practice for Selection of Blood for in vitro 
Evaluation of Blood Pumps 
ASTM: F2514 − 08 
Finite Element Analysis (FEA) of Metallic Vascular 
Stents Subjected to Uniform Radial Loading 
 
 
 
 
2.5 Performance Criteria 
 
 
It has been demonstrated through prior research that a pressure 
generation of 1 - 5mmHg within the cardiovascular circulation is required to bring 
the circulation to near-normal physiological conditions [1]. Hence, the energy 
gain is important to compute as it helps determine the impact of the pumps on 
the energy of the system. By calculating change in hydraulic energy, it can be 
determined whether the axial pumps are effective in generating any energy gain 
in the pulmonary arteries [28]. Sufficient pressure and energy generation will 
allow the system to serve the purpose of an artificial right ventricle by pushing the 
blood through the pulmonary arteries. Increased pressure reduces fluid 
congestion in the pulmonary arteries while increasing cardiac output, thus 
reducing many of the symptoms observed in Fontan patients. 
In consideration of blood trauma in a rotating machine, such as a blood 
pump, we seek to ensure that shear stress levels remain below 425Pa and 
exposure time below 620ms [29]. It is also desired that blood damage indices 
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remain below 2% [30].For these reasons, shear stress, pressure generation, and 
blood damage indices are determined.  
 
 
2.6 Design Factors 
 
 
For the simulations, the following design factors were chosen to evaluate: 
IVC/SVC flow rate, pump rotational speed, rotational speed difference between 
pumps, twist angle of impeller blades, cage design, and LPA/RPA outlet 
pressures.  
Table 3 lists the ranges and variations selected for the design factors. 
Venous return flow rates were evaluated at 1-4 L/min. This is representative of 
flow rates in resting Fontan patients [31]. For rotational speed, 2000, 3000, and 
4000 RPM were selected because previous research has shown pressure rises 
meeting design criteria with rotational speeds of 2000 to 6000 RPM for one pump 
[32]. A lower range was chosen for the current analysis as this design has two 
axial pumps and more shear stresses and blood damage can result. Additionally, 
further understanding was developed of the effects of varying rotational speeds 
on pressure generations by evaluating the pumps with unequal rotational speeds. 
Previous studies at BioCirc have evaluated twist angle of the impeller blades 
from 60-600° at higher rotational speeds and showed high pressure rises in 
cases above 100° [33]. This study evaluated a middle range (200-500°) at lower 
rotational speeds to evaluate whether the new configuration can demonstrate 
pressure rises within the same ranges. Figure 4 to Figure 7 show the models 
created to represent pumps with varying blade twist angles. As discussed earlier, 
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studies have shown that cage filaments assist energy transfer by the impeller 
rotation. Thus, two cage filament patterns will be assessed to understand the 
contribution of the design in generating hydraulic energy. The models generated 
for straight and twisted filaments can be seen in Figure 8 and Figure 9, 
respectively. LPA and RPA were chosen to have equal pressures and were 
evaluated in the 9mmHg - 24mmHg range. Mean pulmonary arterial pressure is 
approximately 15mmHg, while pressure during diastole can reach 8mmHg [34, 
35]. Fontan physiology results in an elevated pulmonary vascular resistance, for 
which reason the higher range of pressures are also being evaluated [36]. 
 
 
 
Table 3: List of design factors evaluated for proof-of-concept of device 
Design Factors Ranges Evaluated 
Inlet Flow Rates (IVC/SVC) 1-4 L/min 
Pump Rotational Speeds 2000, 3000, 4000 RPM 
Unequal Pump Rotational Speeds 
+1000, +500, -500, -1000 RPM (Left-
Right) 
Twist Angle of Pump Blades 200°, 300°, 400°, 500° 
Cage Design Straight, twisted filaments 
Outlet Pressures (LPA/RPA) 9mmHg - 24mmHg 
 
 
 
 
Figure 4: 200° impeller 
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Figure 5: 300° impeller 
 
 
 
 
Figure 6: 400° impeller (original) 
 
 
 
 
Figure 7: 500° impeller 
 
 
 
 
Figure 8: Straight cage design 
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Figure 9: Twisted cage design 
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3. Computational Methods 
 
 
 
3.1 Background 
 
 
As in this thesis project, computational methods have long been used for 
simulations of the Fontan physiology to analyze hemodynamics in the system 
and in the development of rotary blood pumps for placement and implementation 
in the cardiovascular system. Computational fluid dynamics (CFD) analyses have 
also been utilized to surgically optimize the TCPC through examination of flow 
dynamics and energy losses. Various configurations of the TCPC exist, and 
researchers continue to optimize the physiology through examination of factors, 
such as shear stresses and flow stagnation, to improve long-term health of 
patients [37]. This study will also utilize CFD analysis methods to simulate and 
analyze the coupling of the mechanical pump design with the TCPC. Thus, 
design factors can be computationally evaluated to optimize pump performance. 
 
 
3.3 Computational Fluid Dynamics 
 
 
ANSYS CFX 15.0 software (ANSYS, Inc., Canonsburg, PA, USA) was 
employed to execute computational fluid dynamics analysis within the TCPC with 
the insertion of this pump design. The CFX-Mesh program was used to generate 
a mesh of tetrahedral elements for each of the three-dimensional model 
components developed in SolidWorks [24]. 
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The generated mesh components were imported and assembled into the 
ANSYS-CFX solver. The CFX-Solver uses a hybrid finite-element/finite-volume 
approach to solve the Reynolds-averaged Navier-Stokes equations for each 
simulation. The program solves for turbulent flow conditions in the model.  
ANSYS-CFX runs the simulation, as seen in Figure 10, until the solution 
reaches the pre-set convergence value of 1 x 10-3 [38]. This value provides a 
tolerance for the acceptable accuracy of the approximation [39]. Once the 
simulation has converged, post-processing tools from CFX-Post are used to 
visualize and analyze the results of the CFD simulations. 
 
 
 
 
Figure 10: CFX-Solver for one of the simulations as convergence value 
approaches 1 x 10-3 
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3.3.1 Navier-Stokes Equations 
 
 
The fluid solver of the ANSYS CFX solves the Navier-Stokes equations. 
The Navier-Stokes equations are derived from the conservation of momentum 
equations. The conservation of mass equation, as seen in Equation 1, is 
developed based on the concept that mass flow into a controlled volume must 
equal mass flow out of the volume [38].  
 
𝜕𝜌
𝜕𝑡
+  
𝜕
𝜕𝑥𝑖
(𝜌𝑈𝑖) = 0 
Equation 1: Conservation of Mass 
 
In the equation above, Ui is the velocity vector of flow, t is time, and ρ is 
the fluid density. The conservation equation of momentum, ρUi, can then be 
developed: 
 
𝜕
𝜕𝑡
(𝜌𝑈𝑖) +  
𝜕
𝜕𝑥𝑗
(𝜌𝑈𝑖𝑈𝑗) = −
𝜕𝑃
𝜕𝑥𝑖
−
𝜕𝜏𝑖𝑗
𝜕𝑥𝑗
+  𝜌𝑓𝑖 
Equation 2: Conservation of Momentum 
 
In Equation 2, xi and xj are the special variables, P is the pressure, τij is 
the viscous stress tensor, and fi is the body force vector. The gravity component 
of the equation is not considered in Equation 2 for the purpose of this analysis 
as the force of gravity is negligible in comparison to the centripetal force 
generated by the rotary axial pump. The stress tensor can be further defined as 
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below for a Newtonian fluid (displays a linear relationship between shear stress 
and shear strain rate) [38, 39].  
 
𝜏𝑖𝑗 =  −𝜇𝑏𝛿𝑖𝑗
𝜕𝑈𝑘
𝜕𝑥𝑘
−  𝜇𝑣 (
𝜕𝑈𝑖
𝜕𝑥𝑗
− 
𝜕𝑈𝑗
𝜕𝑥𝑖
) 
Equation 3: Viscous stress tensor equation 
 
In Equation 3, μv is the dynamic viscosity, μb represents the bulk viscosity 
(2/3*μv), and 𝛿𝑖𝑗 is the Kronecker delta [38]. 
 
3.3.2 Reynolds Averaging Navier Stokes (RANS) Method 
 
 
In turbulent flow conditions, variable quantities tend to fluctuate 
continuously. For this reason, the Reynolds-averaging procedure is used. This 
method defines the scalar values as the sum of the mean and fluctuating 
components. 
With the application of the Reynolds-Averaging form and the assumption 
that flow is of an incompressible fluid displaying constant density, Equations 1-3 
become the following: 
 
𝜕𝑈?̅?
𝜕𝑥𝑖
 = 0 
Equation 4: Averaged conservation of mass 
 
𝜕
𝜕𝑡
(𝜌𝑈?̅?) +  
𝜕
𝜕𝑥𝑗
(𝜌𝑈?̅?𝑈?̅?) = −
𝜕?̅?
𝜕𝑥𝑖
−
𝜕
𝜕𝑥𝑗
(𝜏𝑖𝑗 +  𝜌𝑢𝑖𝑢𝑗) 
Equation 5: Averaged conservation of momentum 
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𝜏𝑖𝑗̅̅ ̅ = −𝜇𝑣 (
𝜕𝑈?̅?
𝜕𝑥𝑗
−  
𝜕𝑈?̅?
𝜕𝑥𝑖
) 
Equation 6: Averaged viscous stress tensor for an incompressible fluid 
 
ANSYS-CFX utilizes this Reynolds-averaged Navier-Stokes method to 
approximate the flow conditions in the pump. The challenge with this method is 
the emergence of higher-order correlations in the flow equations, which result in 
a “closure problem”. In order to determine these correlations or unknown stress 
tensor components, a closure model is required [38, 39]. 
 
 
3.3.2 Turbulence Modeling 
 
 
The Reynolds number (Re) was calculated using the equation below. 
Based on the calculation, Re is on the order of 104, thus showing that turbulent 
flow dominates in the system [40]. This supports the use of turbulence modeling 
for the computational analysis. 
 
𝑅𝑒 =  
𝜔𝑟𝐿𝜌
𝜇
= 23,200 
Equation 7: Reynolds number equation 
 
A κ-ε turbulence model was used "to close" the simulation-based 
equations. A study comparing different turbulence models showed that the κ-ε 
model had the best correlation to the experimental data, within a 10-20% range 
[40]. This model utilizes two transport equations to further analyze the turbulence 
conditions and allows for equation closure. This model solves the two equations 
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for κ and ε. The κ represents the turbulent kinetic energy and the ε is the 
dissipation rate [38, 41]. The dissipation rate can be further elaborated as the 
quantity of κ per mass and time that is converted to internal fluid energy. 
Turbulent kinetic energy can be related to the turbulent velocity scale (Vt) with the 
following relationship: κ = Vt
2. The dissipation rate of κ can be determined with 
the following equation: 
 
𝜀 =  
κ3/2
𝑙𝑡
 
Equation 8: Equation relating turbulent kinetic energy and dissipation rate 
 
In the above equation, lt represents the turbulent length scale. Both κ and 
ε can then be utilized to determine the turbulent viscosity (μt). Thus, turbulence 
modeling allows the estimation of turbulent viscosity and turbulence kinetic 
energy to approximate the flow equations in the free shear regions [38]. 
 
 
3.3.3 Boundary and Flow Conditions for the Simulations 
 
 
Simulations were performed under steady flow conditions with the 
assumption that the vessel walls are rigid. No slip boundary conditions were 
applied to the solid boundaries, which include the catheter wall, TCPC vessel 
walls, stent, and blades of the two pumps. The pump boundaries were defined in 
the rotating reference frame. Additionally, the boundary between the IVC vessel 
wall and catheter wall, and boundaries surrounding the pump rotors were defined 
as fluid-fluid interfaces. These boundaries were created for developing the mesh; 
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however no actual wall will exist in the real design. The fluid-fluid boundary 
condition allows for the unrestrictive flow of fluid between the two areas. The 
mass inflow rate was split as 60%/40% for the IVC/SVC. For the simulations, 
fluid viscosity of 0.0035 kg/m*s and density of 1050 kg/m3 were selected to 
represent blood properties. Fluid viscosity of 0.0035 kg/m*s (3.5 cP) corresponds 
to a hematocrit of approximately 33%. This is characteristic of blood properties of 
pediatric patients with congestive heart disease [38]. 
 
 
3.3.4 Blood Damage Modeling 
 
 
With blood contacting the rotating surfaces in blood pumps, there is a risk 
of hemolysis and thrombosis. For this reason, a blood damage analysis using the 
CFD models was performed. As mentioned, the goal is to have the stress values 
below 425Pa for 600 milliseconds, and a blood damage index of less than 2% in 
development of the double axial blood pump device. To analyze for blood 
damage, a technique was used to calculate for the six components of stress 
tensor and scalar stress (σ). The scalar stress values were calculated according 
to Equation 9 to estimate the amount of stress endured by the blood.  
 
𝜎 = (
1
6
∑(𝜎𝑖𝑖 −  𝜎𝑗𝑗)
2
+  ∑ 𝜎𝑖𝑗
2 )
1/2
 
Equation 9: Shear stress 
 
34 
 
 
 
The above equation includes the i and j components of the stress tensor. 
Blood damage index can be calculated based on the power law relationship 
between scalar stress and particle exposure time as shown in Equation 10. 
 
𝑑𝐻𝑏
𝐻𝑏
= 𝐶 × 𝜎𝛼  × 𝑇𝛽 
Equation 10: Change in hemoglobin content 
 
In Equation 10, dHb represents the change in hemoglobin content from blood 
damage, Hb denotes hemoglobin content, σ is the scalar stress (calculated in 
Equation 9), and T is the fluid exposure time to the scalar stress. C, α, and β all 
represent proportionality constants determined through the regression of 
experimental data. To calculate for scalar stress and particle exposure time, fluid 
streamlines were analyzed by simulating the release of 350 particles within the 
system. Both scalar stress and exposure time were summed for the streamlines. 
Based on Equation 10, the following power law equation can be used to 
determine the possibility of blood cell damage as it passes through the axial 
blood pumps. 
 
𝐷 =  ∑ (1.8 × 10−6)
𝑜𝑢𝑡𝑙𝑒𝑡
𝑖𝑛𝑙𝑒𝑡
× 𝜎1.991 × ∆𝑡0.765 
Equation 11: Blood damage index 
 
D represents the blood damage index, t is the exposure time, and σ is the 
scalar stress. Inlet indicates the entrance of the fluid flow (SVC and IVC), and 
outlet represents the exit (LPA and RPA). As derived from Equation 10, D 
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represents the percent difference in hemoglobin levels, which occurred due to 
blood damage, divided by the initial hemoglobin quantity [28]. To complete this 
calculation, an analysis code was utilized with the MATLAB program (Matlab, 
The Mathworks Inc., Natick, MA, USA). Based on the design criteria, D below 
0.02 (2%) is sought for this design. The constant and exponential values in 
Equation 11 were determined with experimental data regression in a Couette 
viscometer. The study had fluid stress of 40 to 700Pa with exposure times of 
0.0034 to 0.6 seconds. These values are representative of stress and exposure 
time levels found in blood pumps [42, 43]. Table 4 represents the conditions 
tested for blood damage indices, including rotational speed, flow rate, degree 
twist of blades, outlet pressures, and cage design. 
 
 
3.3.5 Energy Augmentation Estimations 
 
 
A control volume approach was used to determine the energy generated 
in the pulmonary arteries. With the below equations, the amount of energy that 
would be gained or lost with both axial pumps can be estimated:  
 
𝐸𝑙𝑜𝑠𝑠 = − ∑(𝑃𝑠𝑡𝑎𝑡𝑖𝑐 + 0.5𝜌𝑢𝑘𝑢𝑘)𝑢𝑖𝑛𝑖𝐴𝑖 
=  ∑(𝑃𝑡𝑜𝑡𝑎𝑙_𝑖𝑛)𝑄𝑖𝑛𝑙𝑒𝑡 −  ∑(𝑃𝑡𝑜𝑡𝑎𝑙_𝑜𝑢𝑡)𝑄𝑜𝑢𝑡𝑙𝑒𝑡 
Equation 12:Energy loss 
 
𝑃𝑡𝑜𝑡𝑎𝑙 = 𝑃𝑠𝑡𝑎𝑡𝑖𝑐̅̅ ̅̅ ̅̅ ̅̅ + 0.5𝜌𝑢𝑖𝑢𝑖̅̅ ̅̅ ̅̅  
Equation 13: Total pressure 
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𝑄𝑖 = 𝑢𝑖𝐴𝑖 
Equation 14: Flow rate 
 
In the above equations, Eloss is the rate of energy consumption in the 
pulmonary arteries and Ptotal is the total pressure, which includes the static (Pstatic) 
and kinetic components. Q represents the flow rates at the inlets (SVC and IVC) 
and outlets (LPA and RPA). The inlet pressures were determined at the point 
before the pumps and the outlet pressures were determined at the point after the 
pumps. This represented the total pressure and allowed for estimation of total 
energy change in the pump regions. Also, ui and uk denote the velocity 
components, while ni signifies the component of the normal vector of the outer 
surface and Ai represents the area [28].  
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4. Computational Results 
 
 
 
4.1 Analysis 1: Pump Rotational Speed Variation 
 
 
Pump performance at varying rotational speeds was modeled with CFD 
simulations. These conditions were evaluated and utilized for comparisons with 
condition and design variations during future experiments. For this analysis, the 
meshed design included a 400° impeller for each axial pump. Additionally, these 
conditions included a set blood viscosity of 0.0035 kg/m*s and density of 1050 
kg/m^3. The inlet flow distribution was chosen to be 60% IVC and 40% SVC and 
outlet pressures of LPA and RPA was set to 18 mmHg. Three different pump 
rotational speeds were compared for this experiment: 2000 RPM, 3000 RPM, 
and 4000 RPM. Simulations were run for each rotational speed with varying flow 
rates: 1.0 to 4.0 L/min at 0.25 L/min intervals.  
Figure 11 and Figure 12 show the pressure generations for each pump 
and rotational speed with increasing flow rate. Comparison of left and right 
pumps shows that performance with identical conditions for each pump result in 
near-identical pump performance. The graphs also demonstrate an increase in 
pressure generation with increasing rotational speed, and a decrease in pressure 
generation with increasing flow rate. Pressure generation ranged from 
approximately 1.84-8.53mmHg, with the greatest pressure increase at 4000 RPM 
and 1 LPM and the lowest increase at 2000 RPM and 3 LPM. Energy generation 
in the pulmonary arteries versus flow rate was illustrated in Figure 13. This 
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demonstrated an increase in energy transfer with greater rotational speed and 
flow rate. Energy increase ranged from 4.57 mW (1 LPM, 2000 RPM) to 65.2 
mW (4 LPM, 4000 RPM).  
 
 
 
 
Figure 11: Graphical representation of pressure generation in the left pump region 
with increasing flow rate for 2000, 3000, 4000 RPM 
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Figure 12: Graphical representation of pressure generation in the right pump 
region with increasing flow rate for 2000, 3000, 4000 RPM 
 
 
 
 
Figure 13: Graphical representation of energy generated in the pulmonary arteries 
with increasing flow rate for 2000, 3000, 4000 RPM 
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4.2 Analysis 2: Impeller Blade Degrees Variation 
 
 
For the second experiment, three additional models were created with 
different impeller designs. While the original design had pump impellers with 400° 
twisted blades (Figure 6) the new models included 200°, 300°, and 500° 
impellers (Figure 4, Figure 5, and Figure 7). This analysis compared the pump 
performance with varying angles of impeller blades. For this analysis, the blood 
viscosity, blood density, inlet flow distribution, outlet pressures were kept the 
same as Analysis 1. The flow rate was fixed at 3.0 LPM and each model’s 
performance was simulated at 2000 RPM, 3000 RPM, and 4000 RPM. For this 
experiment, both pumps were set to equal conditions. 
Figure 14 shows the increase in pressure for each rotational speed with 
increasing twist of the blades for the left pump only. Only the left pump was 
displayed since Analysis 1 demonstrated that the pumps show similar 
performances when set to equal conditions. Pressure increase ranges from 1.56 
to 8.94mmHg. As seen in Figure 14, pressure generation increases with 
increasing twist and peaks at 300°, after which the pressure generation begins to 
decrease. For each rotational speed, the lowest pressure generation occurs at 
500°. Figure 15 shows the energy generation in the pulmonary arteries with 
increasing impeller blade twist for each rotational speed. This showed a range of 
11mW (500°, 2000 RPM) - 59mW (300°, 4000 RPM). This demonstrated a 
similar pattern as the pressure generation graph, with 300° showing the greatest 
energy generation for each rotational speed and 500° showing the least energy 
generation for all rotational speeds. 
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Figure 14: Graphical representation of pressure generation in the left pump region 
with increasing twist of impeller blade for 2000, 3000, 4000 RPM 
 
 
 
 
Figure 15: Graphical representation of energy generation in the pulmonary 
arteries with increasing twist of impeller for 2000, 3000, 4000 RPM 
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4.3 Analysis 3: Unequal RPMs 
 
 
For this next experiment, the left and right pumps had unequal RPMs to 
examine how significant these changes are on pump performance. For this 
analysis, the left pump was fixed at 3000 RPM and the right pump was varied 
from 2000 RPM to 4000 RPM in intervals of 500. All other parameters were kept 
the same as Analysis 1. Data of both pumps at 3000 RPM was leveraged from 
Analysis 1 for comparison. 
In Figure 16, it can be seen that increasing rotational speed in the right 
pump generated slight but negligible pressure increase in the left pump. As 
expected in the right pump (Figure 17), a significant pressure increase was 
found with higher RPMs. RPMs in 2000, 2500, and 3000 showed pressure 
generation within the desired 1 - 5mmHg range. Figure 18 shows an increasing 
energy gain with increasing right pump RPM. As expected, the effect of rotational 
speed on energy generation increases with increasing flow rate. 
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Figure 16: Graphical representation of pressure generation in the left pump region 
with increasing flow rate for constant left pump RPM (3000 RPM) and varying right 
pump RPM (2000 – 4000 RPM) 
 
 
 
 
Figure 17: Graphical representation of pressure generation in the right pump 
region with increasing flow rate for constant left pump RPM (3000 RPM) and 
varying right pump RPM (2000 – 4000 RPM) 
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Figure 18: Graphical representation of energy generation in the pulmonary 
arteries with increasing flow rate for constant left pump RPM (3000 RPM) and 
varying right pump RPM (2000 – 4000 RPM) 
 
 
 
 
4.4 Analysis 4: Cage Design 
 
 
Including cages to surround the axial pumps is important for stability as 
well as vessel protection [26]. This analysis examined the Analysis 1 conditions 
with pumps at 3000 RPM held within straight and twisted cages. Figure 8 shows 
the straight cage design and Figure 9 shows the twisted cage design. Both cage 
designs were generated on SolidWorks and new pump models were meshed for 
the studies. Both cages consisted of 6 filaments surrounding the pump and 
extending axially. The twisted cage design (Figure 9) was such designed that the 
filaments twist with the blades.  
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Figure 19 and Figure 20 show performance comparisons of the two cage 
design models with data from Analysis 1. For all simulations, left and right pumps 
were set at 3000 RPM. Both figures show that the insertion of a cage resulted in 
a significant decrease in pressure and energy generation. The twisted cage 
design further reduced these values when compared to the straight cage design. 
Another observation was that the insertion of a cage reduced the level of effect 
flow rate had on pressure and energy generation. 
 
 
 
 
Figure 19: Graphical representation of pressure generation in the left pump region 
with increasing flow rate for no cage, straight cage, and twisted cage designs 
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Figure 20: Graphical representation of energy generation in the pulmonary 
arteries with increasing flow rate for no cage, straight cage, and twisted cage 
designs 
 
 
 
 
4.5 Analysis 5: LPA and RPA Variation 
 
 
The final analysis varied LPA and RPA outlet pressures to examine the 
change in SVC and IVC inlet pressures. Increasing rotational speed of the pumps 
when the LPA and RPA outlet pressures are low could theoretically decrease 
inlet pressures in the SVC and IVC. A significant pressure drop can be 
detrimental as it could cause the vessel to collapse. Since the SVC constituted a 
smaller percentage of the flow rate, in comparison to IVC, SVC was expected to 
show lower inlet pressures. Thus, Figure 21 plots SVC inlet pressure changes 
with changing pump RPM for LPA and RPA outlet pressures ranging from 9 to 
24mmHg. All simulations for this analysis were done with 3 L/min, 400° impeller 
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pumps, and a straight cage design. The straight cage design was utilized as it 
was known a cage design would be required to support the pumps. The 18mmHg 
LPA and RPA outlet pressure results were leveraged from straight cage design 
results in Analysis 4. 
The results from this analysis show slight decreases in inlet pressures with 
increasing rotational speed. Increasing RPM from 2000 to 4000 RPM resulted in 
a pressure drop of less than 5mmHg. Additionally, increasing the outlet 
pressures by 3mmHg also resulted in 3mmHg increases in SVC pressures. The 
lowest inlet pressure was 16.49 mmHg when the outlet pressures were 9mmHg 
and the rotational speed was 4000 RPM. 
 
 
 
 
Figure 21: Graphical representation of SVC inlet pressure with increasing 
rotational speed for varying LPA and RPA outlet pressures 
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4.6 Blood Damage Analysis 
 
 
 Certain design configurations were analyzed while simulating the release 
of 350 particles into the system to conduct a blood damage analysis. Table 4 
shows the list of simulations that were analyzed for blood damage indices, total 
exposure time, and shear stresses. The results include mean and maximum 
exposure times and damage indices, as well as maximum shear stresses. 
 Most mean exposure times were approximately 1 second. However, 
Simulation #1 had the highest mean exposure time at 2.17 seconds. Simulations 
#12, 13, 14, and 15 had the lowest mean exposure times (all between 0.7-0.8 
seconds). Simulations #1, 3, 6, and 10 showed max exposure times greater than 
5 seconds, while Simulation #14 showed the lowest maximum exposure time of 
1.91 seconds. Examining the damage indices of all simulations showed that the 
mean damage indices ranged from 0.05% to 0.42%. Simulation #6 had the 
highest maximum percentage at 0.64%. Maximum shear stresses ranged from 
253.3Pa (Simulation #3) to 541.8Pa (Simulation #7). 
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Table 4: Blood damage analysis with simulations examined and results 
Analysis 1 
# LPM 
Impeller 
(°) 
Left 
RPM 
Right 
RPM 
Cage 
LPA/RPA 
(mmHg) 
Time 
(s): 
Mean 
Time 
(s): 
Max 
DI: 
Mean 
DI: 
Max 
Max 
Shear 
Stress 
1 1 400 3000 3000 None 18 2.170 5.167 0.05% 0.05% 346.3 
2 2 400 3000 3000 None 18 1.207 3.605 0.08% 0.15% 312.4 
3 3 400 2000 2000 None 18 1.171 6.677 0.20% 0.38% 253.3 
4 3 400 3000 3000 None 18 0.869 2.260 0.20% 0.37% 269.2 
5 3 400 4000 4000 None 18 0.852 3.047 0.22% 0.35% 523.9 
6 4 400 3000 3000 None 18 0.935 7.696 0.42% 0.64% 428.2 
Analysis 2 
 LPM 
Impeller 
(°) 
Left 
RPM 
Right 
RPM 
Cage 
LPA/RPA 
(mmHg) 
Time 
(s): 
Mean 
Time 
(s): 
Max 
DI: 
Mean 
DI: 
Max 
Max 
Shear 
Stress 
7 3 200 3000 3000 None 18 0.805 2.834 0.24% 0.40% 541.8 
8 3 300 3000 3000 None 18 0.791 2.849 0.20% 0.39% 511.8 
9 3 500 3000 3000 None 18 0.890 3.896 0.23% 0.35% 260.9 
Analysis 3 
 LPM 
Impeller 
(°) 
Left 
RPM 
Right 
RPM 
Cage 
LPA/RPA 
(mmHg) 
Time 
(s): 
Mean 
Time 
(s): 
Max 
DI: 
Mean 
DI: 
Max 
Max 
Shear 
Stress 
10 3 400 3000 2000 None 18 1.062 7.666 0.14% 0.41% 281.0 
11 3 400 3000 4000 None 18 0.840 2.414 0.30% 0.31% 453.5 
Analysis 4 
 LPM 
Impeller 
(°) 
Left 
RPM 
Right 
RPM 
Cage 
LPA/RPA 
(mmHg) 
Time 
(s): 
Mean 
Time 
(s): 
Max 
DI: 
Mean 
DI: 
Max 
Max 
Shear 
Stress 
12 3 400 3000 3000 Straight 18 0.719 2.104 0.19% 0.38% 257.9 
13 3 400 3000 3000 Twisted 18 0.792 2.363 0.19% 0.29% 261.3 
Analysis 5 
 LPM 
Impeller 
(°) 
Left 
RPM 
Right 
RPM 
Cage 
LPA/RPA 
(mmHg) 
Time 
(s): 
Mean 
Time 
(s): 
Max 
DI: 
Mean 
DI: 
Max 
Max 
Shear 
Stress 
14 3 400 3000 3000 Straight 9 0.738 1.910 0.19% 0.41% 317.1 
15 3 400 3000 3000 Straight 24 0.747 2.372 0.19% 0.38% 337.5 
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5. Discussion 
 
 
 
5.1 Overview 
 
 
Every year, there are 2000 single ventricle births. The treatment and 
management of patients with single ventricle physiology is expensive, with a cost 
of $1.4 billion yearly [3, 4]. Such severe cardiovascular defects often lead to a 
number of health complications, for which patients have to often undergo open-
heart surgeries. These procedures culminate with a Fontan physiology, which 
although result in a functional cardiovascular system, comes with numerous long-
term challenges. Fontan patients have long term symptoms such as abnormal 
cardiovascular hemodynamics, increased systemic venous pressure, 
supraventricular arrhythmias, reduced exercise capacity, and protein-losing 
enteropathy [2, 9]. Cardiac transplantation, often needed for Fontan patients, 
involve large wait times and require significant reconstruction of the veins and 
arteries, ultimately resulting in 44% operative mortality rates within Fontan 
patients [2, 9, 10]. 
 This thesis discussed a novel stent and device combination design to 
address this problem. The device involves blood collection at the TCPC junction 
with a lumen stent, which is directed to and propelled by the axial blood flow 
pumps in the pulmonary arteries. This design hopes to augment energy in the 
system and generate the pressure needed to bring the physiology to near-normal 
conditions. The thesis involves a discussion of computational analyses through 
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the execution of 156 simulations to test pump performance while targeting design 
parameters.  
 
 
5.2 Pressure and Energy Generations 
 
 
In studying the effect of pump rotational speed and flow rate on pressure 
generation in Analysis 1 (Figure 11 and Figure 12), increasing flow rate resulted 
in a decrease in pressure generation. This behavior is expected as based on the 
Navier-Stokes Equation. However this effect was diminished in the lowest 
rotational speed (2000 RPM). Additionally, pressure increased with greater 
rotational speeds. Based on the design criteria of 1 - 5mmHg pressure 
generation, 2000 RPM and 3000 RPM performed within the range for all flow 
rates, while 4000 RPM had significantly higher pressure generations. Similar 
results were found for Analysis 2: both 2000 and 3000 RPM performed in the 
range specified in the design criteria for all impeller degrees, while 4000 RPM 
showed significantly higher pressure increases than 1- 5mmHg (see Figure 14). 
In comparison, it can be seen in Figure 19, despite the decreases in pressure 
generation with the cage designs, all values met the design criteria of 1 - 5mmHg 
increase in pressure. 
In comparing Figure 16 and Figure 17, it can be seen that 1000 RPM 
differences between the two pump rotational speeds, when studying higher 
rotational speeds (3000 and 4000 RPM) resulted in a difference of approximately 
3mmHg pressure difference in the left and right pump regions. However, when 
studying lower rotational speeds (2000 RPM and 3000 RPM) with a difference of 
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1000 RPM between the two pumps, a 2mmHg pressure difference was observed 
between the two regions. Rotational speed difference of 500 RPM resulted in a 
1.5mmHg pressure difference in the left and right pump regions in both higher 
and lower rotational speeds (3500 and 3000 RPM vs 2500 and 3000 RPM). 
Thus, these results show that with lower rotational speeds, increasing differences 
between the pump rotational speeds do not have a significant impact on pressure 
differences in the two pump regions. 
With high rotational speeds and low outlet pressures, pump rotation could 
result in a large pressure drop in the SVC and IVC. This can be a major concern 
as a severe pressure drop could result in the vessel to collapse. From Figure 21, 
it can be seen that with the lowest outlet pressure (9 mmHg) and highest 
rotational speed of 4000 RPM, SVC inlet pressure remains at 16.5 mmHg. Thus 
vessel suction is not a concern with this design and parameters. 
In comparing cage designs, the straight cage showed higher pressure and 
energy rises than the twisted cage design. This is expected because the straight 
cage filaments redirect the blood flow by reducing its vorticity, thus supporting 
energy transfer. However, since the twisted cage filaments twist in the same 
direction of the blades, they do not redirect the blood flow, thus do not aid energy 
transfer. 
As discussed in the results, significant increases in energy were observed 
both with increasing flow rates and increasing rotational speed (Figure 13). 
Similar to pressure augmentation, twist of pump blades had a positive 
relationship with energy increase until 300°. At higher degrees (400 and 500), an 
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inverse relationship existed between the blade twist and energy generation 
(Figure 15). This can be explained because a small number of blades provides 
lower amount of propulsion to the fluid. However, a large number of blades with 
minimal spacing in between restricts fluid flow within the passage, also resulting 
in a less effective pump. Thus, 300° seems to represent the optimal twist of 
blades. As seen in Figure 20, addition of a cage slightly reduced the impact of 
increasing flow rate on energy generation; however significant increases in 
energy did exist with increasing flow rate for both cage designs. 
 
 
5.3 Blood Damage Analysis 
 
 
As previously discussed, shear stresses below 425 Pa, exposure times 
below 620 ms, and blood damage indices below 2% were selected as design 
criterions for the blood pumps. As the results discussed, all mean exposure times 
exceeded the desired exposure time of 620 ms, since the lowest means were 
between 0.7 and 0.8 seconds. However, the commonality between the lowest 
exposure times were that they were all simulations including a straight cage or 
twisted cage support, further confirming the need for a cage support for the 
design. The twisted cage support had a slightly higher mean exposure time than 
the straight cage support, but a lower max damage index. This is expected 
because existing studies have also shown a twisted cage design with filaments 
twisting with the blades to perform poorly in comparison to other cage designs 
(including straight cage) [26]. Varying the impeller blade twist did not seem to 
show significant changes in exposure time (in comparing simulations #4, 7-9). 
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However increasing rotational speed of the pumps reduced the mean exposure 
time (in comparing simulations #3-5), as would be expected since the blood has 
more energy and is able to exit quicker. Examining the damage indices of all 
simulations showed that the max percentage was 0.64% (for simulation #6), 
which still remained below the 2% design criteria for the pumps. Many shear 
stress values were above the 425Pa criteria: Scenarios 5, 7, 8, and 11. Two of 
these scenarios had blade degree twists lower than 400 degrees, while the other 
two scenarios had one or two pumps rotating at 4000 RPM. This shows that 
lower degree twists and higher pump rotational speeds result in higher shear 
stresses. 
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6. Future Work and Conclusions 
 
 
 
6.1 Limitations and Future Work 
 
 
In this study, computational modeling was limited to examining pump 
performance in idealized and simplified conditions. As the boundary conditions, 
vessel walls were indicated as rigid bodies, and both the density and viscosity of 
blood were kept constant. Additionally, the analyses were done assuming steady 
state conditions. Further studies can examine transient flow conditions, vessel 
compliance conditions, and blood density and viscosity variability effects. 
Additionally, this study idealized the TCPC with complete alignment of the SVC 
and IVC. Future studies can alter the TCPC model to include a 1-diameter offset 
between the SVC and IVC central axes and/or consider an anatomical TCPC 
model. Pump performance can be further analyzed with this change, and 
rotational speeds of the left and right pumps can be varied according to the 
findings of Analysis 3 to accommodate this difference.  
Additionally, hemolysis testing can be conducted per the ASTM standards 
discussed in Section 2.4. These experimental studies will allow further analysis of 
pump performance and comparisons with the numerical analyses executed in 
this thesis.  
Multiple variations of cage design and degrees twist of the pump blades 
could not be analyzed due to time constraints. However, future studies can 
examine different configurations of the twisted cage design. This data showed 
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that the straight cage performed better than the twisted cage with filaments 
twisting in the same direction as the pump blades. However, the incorporation of 
a cage design resulted in a significant drop in pressure generation when 
compared to a no-cage design. Thus, a cage design that can enhance energy 
transfer while minimizing blood trauma is desired. Previous studies have 
examined numerous cage filament patterns that can also be analyzed for this 
design [26]. 
A study by Chopski et al. [33] examined degree twist of the blades for 
intravascular axial flow blood pump placement in the IVC. Interestingly, highest 
pressure generations were found with 380 and 400 degree twists. The findings of 
this thesis showed that 300 degrees twist had the highest pressure generation 
and 400 degrees twist performed lower than 200 degrees twist. This difference 
may be due to the novel stent and pump configuration, and also due to the 
difference in pump placement. Shear stresses may also need to be examined at 
smaller intervals as 300 and 400° twists had significantly different max shear 
stresses. Thus, future work can also further examine the effect of degree twist on 
pressure generation and shear stress by conducting simulations at 25° intervals 
between 200 and 400° to provide a more accurate estimation on the blade twist 
for the greatest pressure generation while maintaining low shear stresses. 
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6.2 Research Conclusions 
 
 
Results found that increasing rotational speed resulted in significant 
increase in pressure, while increasing flow rate resulted in decrease in pressure. 
However, both parameters resulted in significant energy augmentations. Also, in 
comparison to 2000 and 4000 RPM, 3000 RPM showed lowest mean exposure 
time and shear stresses. Additionally, 300 degrees twist of the pump blades 
demonstrated highest pressure increases, but higher blade twists (400° and 
500°) demonstrated lower shear stresses. Results also showed that pressure 
augmentations in the left and right pump regions showed the greatest difference 
when both pumps had high rotational speeds with a difference of 1000 RPM. 
Current cage study results supported existing cage design studies [26]. The 
results showed that the addition of a cage results in reduces blood damage and a 
cage with filaments twisting with the blades performs poorly in comparison to a 
straight filament cage. Although the addition of a cage reduced pressure 
augmentation, it also resulted in lower mean exposure times and shear stresses. 
Lastly, it was found that high pump rotational speeds did not result in negative 
pressures in the venae cavae. Based on the findings, the recommended design 
parameters for the axial pumps are 3000 RPM and 300-400° blade twist with a 
straight cage design. The results show successful initial performance of the novel 
device configuration, and suggestions are provided for further experimental 
testing and computational analysis. This thesis demonstrates significant potential 
of the design to address the current limitations in mechanical assist devices and 
provide bridge-to-transplant for Fontan patients.  
58 
 
 
 
List of References 
 
 
 
 
[1] D. H. Kafagy, T. W. Dwyer, K. L. McKenna, J. P. Mulles, S. G. Chopski, 
W. B. Moskowitz, et al., "Design of axial blood pumps for patients with 
dysfunctional Fontan physiology: computational studies and performance 
testing," Artificial Organs, vol. 39, pp. 34-42, January 2015. 
 
[2] S. S. Bhavsar, J. Y. Kapadia, S. G. Chopski, and A. L. Throckmorton, 
"Intravascular mechanical cavopulmonary assistance for patients with 
failing Fontan physiology," Artificial Organs, vol. 33, pp. 977-987, 
November 2009. 
 
[3] C. A. Russo and A. Elixhauser. (2007). Hospitalizations for birth defects, 
2004. Healthcare Cost and Utilization Project [Online]. Available: 
http://www.hcup-us.ahrq.gov/reports/statbriefs/sb24.pdf [March 12, 2015]. 
 
[4] Columbus Ohio Adult Congenital Heart Disease Program (n.d.). Single 
ventricle defects [Online]. Available:   
https://www.nationwidechildrens.org/Document/Get/129477 [May 2016]. 
 
[5] Academic Dictionaries and Encyclopedias. (n.d.). Tricuspid valve [Online]. 
Available: http://en.academic.ru/dic.nsf/enwiki/149504 [March 12, 2015]. 
 
[6] M. Gewillig, "The Fontan circulation," Heart (British Cardiac Society), vol. 
91, pp. 839-846, June 2005. 
 
[7] The Children's Heart Clinic. (2012). Modified Fontan procedure 
(extracardiac conduit) [Online]. Available:  
 http://www.childrensheartclinic.org/ProcedureIllustrations/Fontan.pdf [May 
10, 2016]. 
 
[8] T. Takken, A. D. T. Harkel, N. Duppen, S. S. Bossers, I. M. Kuipers, M. 
Schokking, et al., "Exercise capacity in children after total cavopulmonary 
connection: lateral tunnel versus extracardiac conduit technique," Journal 
of Thoracic and Cardiovascular Surgery, vol. 148, pp. 1490-1497, October 
2014. 
 
[9] A. L. Throckmorton, S. Lopez‐Isaza, and W. Moskowitz, "Dual‐pump 
support in the inferior and superior vena cavae of a patient‐specific Fontan 
physiology," Artificial Organs, vol. 37, pp. 513-522, June 2013. 
 
59 
 
 
 
[10] M. Petko, R. J. Myung, G. Wernovsky, M. I. Cohen, J. Rychik, S. C. 
Nicolson, et al., "Surgical reinterventions following the Fontan procedure," 
European Journal of Cardio-Thoracic Surgery, vol. 24, pp. 255-259, 
August 2003. 
 
[11] K. L. Rood, S. A. Teele, C. S. Barrett, J. W. Salvin, P. T. Rycus, F. Fynn-
Thompson, et al., "Extracorporeal membrane oxygenation support after 
the Fontan operation," The Journal of Thoracic and Cardiovascular 
Surgery, vol. 142, pp. 504-510, September 2011. 
 
[12] S. D. Gregory, D. Timms, N. Gaddum, D. G. Mason, and J. F. Fraser, 
"Biventricular assist devices: a technical review," Annals of Biomedical 
Engineering, vol. 39, pp. 2313-2328, September 2011. 
 
[13] B. Stiller, I. Adachi, and C. D. Fraser, "Pediatric ventricular assist devices," 
Pediatric Critical Care Medicine, vol. 14, pp. S20-S26, June 2013. 
 
[14] S. Weinstein, R. Bello, C. Pizarro, F. Fynn-Thompson, J. Kirklin, K. 
Guleserian, et al., "The use of the Berlin Heart EXCOR in patients with 
functional single ventricle," Journal of Thoracic and Cardiovascular 
Surgery, vol. 147, pp. 697-704, February 2014. 
 
[15] A. L. Throckmorton and S. G. Chopski, "Pediatric circulatory support: 
current strategies and future directions. Biventricular and univentricular 
mechanical assistance," ASAIO Journal, vol. 54, pp. 491-497, September 
2008. 
 
[16] F. G. Lacour-Gayet, C. J. Lanning, S. Stoica, R. Wang, B. A. Rech, S. 
Goldberg, et al., "An artificial right ventricle for failing Fontan: in vitro and 
computational study," The Annals of Thoracic Surgery, vol. 88, pp. 170-
176, July 2009. 
 
[17] R. B. Medvitz, D. A. Boger, V. Izraelev, G. Rosenberg, and E. G. 
Paterson, "Computational fluid dynamics design and analysis of a 
passively suspended Tesla pump left ventricular assist device," Artificial 
Organs, vol. 35, pp. 522-533, May 2011. 
 
[18] D. Wang, M. Plunkett, J. Lynch, X. Zhou, C. Ballard-Croft, and J. B. 
Zwischenberger, "Wang-Zwische double-lumen cannula leads to total 
cavopulmonary support in a failing Fontan sheep model," The Annals of 
Thoracic Surgery, vol. 91, pp. 1956-1960, June 2011. 
 
 
 
 
60 
 
 
 
[19] D. Wang, G. Gao, M. Plunkett, G. Zhao, S. Topaz, C. Ballard-Croft, et al., 
"A paired membrane umbrella double-lumen cannula ensures consistent 
cavopulmonary assistance in a Fontan sheep model," The Journal of 
Thoracic and Cardiovascular Surgery, vol. 148, pp. 1041-1047, 
September 2014. 
 
[20] G. A. Giridharan, S. C. Koenig, J. Kennington, M. A. Sobieski, J. Chen, S. 
H. Frankel, et al., "Performance evaluation of a pediatric viscous impeller 
pump for Fontan cavopulmonary assist," The Journal of Thoracic and 
Cardiovascular Surgery, vol. 145, pp. 249-257, January 2013. 
 
[21] R. Wang, F. G. Lacour-Gayet, C. J. Lanning, B. A. Rech, P. J. Kilfoil, J. 
Hertzberg, et al., "Initial experience with the development and numerical 
and in vitro studies of a novel low-pressure artificial right ventricle for 
pediatric Fontan patients," ASAIO Journal, vol. 52, pp. 682-692, 
November 2006. 
 
[22] M. D. Rodefeld, J. H. Boyd, C. D. Myers, B. J. LaLone, A. J. Bezruczko, A. 
W. Potter, et al., "Cavopulmonary assist: circulatory support for the 
univentricular fontan circulation," The Annals of Thoracic Surgery, vol. 76, 
pp. 1911-1916, December 2003. 
 
[23] A. L. Throckmorton, J. Y. Kapadia, S. G. Chopski, S. S. Bhavsar, W. B. 
Moskowitz, S. D. Gullquist, et al., "Numerical, hydraulic, and hemolytic 
evaluation of an intravascular axial flow blood pump to mechanically 
support Fontan patients," Annals of Biomedical Engineering, vol. 39, pp. 
324-336, January 2011. 
 
[24] A. L. Throckmorton, S. Lopez-Isaza, E. A. Downs, S. G. Chopski, J. J. 
Gangemi, and W. Moskowitz, "A viable therapeutic option: mechanical 
circulatory support of the failing Fontan physiology," Pediatric Cardiology, 
vol. 34, pp. 1357-1365, August 2013. 
 
[25] S. G. Chopski, O. M. Rangus, E. A. Downs, W. B. Moskowitz, and A. L. 
Throckmorton, "Three‐dimensional laser flow measurements of a patient‐
specific Fontan physiology with mechanical circulatory assistance," 
Artificial Organs, vol. 39, pp. E67-E78, June 2015. 
 
[26] A. L. Throckmorton, E. A. Downs, J. A. Hazelwood, J. O. Monroe, and S. 
G. Chopski, "Twisted cardiovascular cages for intravascular axial flow 
blood pumps to support the Fontan physiology," Artificial Organs, vol. 35, 
pp. 369-375, May 2012. 
 
 
 
61 
 
 
 
[27] A. L. Throckmorton, J. P. Carr, W. B. Moskowitz, J. J. Gangemi, C. M. 
Haggerty, and A. P. Yoganathan, "Uniquely shaped cardiovascular stents 
enhance the pressure generation of intravascular blood pumps," The 
Journal of Thoracic and Cardiovascular Surgery, vol. 144, pp. 704-709, 
September 2012. 
 
[28] A. L. Throckmorton, J. P. Carr, S. A. Tahir, R. Tate, E. A. Downs, S. S. 
Bhavsar, et al., "Mechanical cavopulmonary assistance of a patient‐
specific Fontan physiology: numerical simulations, lumped parameter 
modeling, and suction experiments," Artificial Organs, vol. 35, pp. 1036-
1047, November 2011. 
 
[29] R. Paul, J. Apel, S. Klaus, F. Schugner, P. Schwindke, and H. Reul, 
"Shear stress related blood damage in laminar couette flow," Artificial 
Organs, vol. 27, pp. 517-529, June 2003. 
 
[30] X. Song, A. L. Throckmorton, H. G. Wood, J. F. Antaki, and D. B. Olsen, 
"Computational fluid dynamics prediction of blood damage in a centrifugal 
pump," Artificial Organs, vol. 27, pp. 938-941, October 2003. 
 
[31] V. E. Hjortdal, K. Emmertsen, E. Stenbøg, T. Fründ, M. R. Schmidt, O. 
Kromann, et al., "Effects of exercise and respiration on blood flow in total 
cavopulmonary connection: a real-time magnetic resonance flow study," 
Circulation, vol. 108, pp. 1227-1231, September 2003. 
 
[32] S. S. Bhavsar, W. B. Moskowitz, and A. L. Throckmorton, "Interaction of 
an idealized cavopulmonary circulation with mechanical circulatory assist 
using an intravascular rotary blood pump," Artificial Organs, vol. 34, pp. 
816-827, October 2010. 
 
[33] S. G. Chopski, C. S. Fox, M. L. Riddle, K. L. McKenna, J. P. Patel, J. T. 
Rozolis, et al., "Pressure–flow experimental performance of new 
intravascular blood pump designs for Fontan patients," Artificial Organs, 
vol. 40, pp. 233-242, March 2016. 
 
[34] R. E. Klabunde. (n.d.). Pulmonary Arterial Pressure  [Online]. Available: 
http://www.cvpharmacology.com/clinical%20topics/pulmonary%20hyperte
nsion [2016]. 
 
[35] LiDCO Group plc. (n.d.). Normal hemodynamic parameters [Online]. 
Available: http://www.lidco.com/clinical/hemodynamic.php [April 23, 2016]. 
 
[36] M. Beghetti, "Fontan and the pulmonary circulation: a potential role for 
new pulmonary hypertension therapies," Heart (British Cardiac Society), 
vol. 96, pp. 911-916, June 2010. 
 
62 
 
 
 
[37] T. C. Slesnick and A. P. Yoganathan, "Computational modeling of Fontan 
physiology: at the crossroads of pediatric cardiology and biomedical 
engineering," The International Journal of Cardiovascular Imaging, vol. 30, 
pp. 1073-1084, August 2014. 
 
[38] A. L. Throckmorton, "Computational design and experimental hydraulic 
testing of an axial flow ventricular assist device for infants and children," 
PhD Dissertation, University of Virginia, 2006. 
 
[39] O. Zikanov, Essential computational fluid dynamics vol. 1. Hoboken, N.J: 
Wiley, 2010. 
 
[40] A. L. Throckmorton and A. Untaroiu, "CFD analysis of a Mag-Lev 
ventricular assist device for infants and children: fourth generation design," 
ASAIO Journal, vol. 54, pp. 423-431, 2008. 
 
[41] S. S. Varghese and S. H. Frankel, "Numerical modeling of pulsatile 
turbulent flow in stenotic vessels," Journal of Biomechanical Engineering, 
vol. 125, pp. 445-460, August 2003. 
 
[42] X. Song, A. L. Throckmorton, H. G. Wood, J. F. Antaki, and D. B. Olsen, 
"Quantitative evaluation of blood damage in a centrifugal VAD by 
computational fluid dynamics," Journal of Fluids Engineering, vol. 126, pp. 
410-418, July 2004. 
 
[43] G. Heuser and R. Opitz, "A Couette viscometer for short time shearing of 
blood," Biorheology, vol. 17, pp. 17-24, 1980. 
 
 
 
 
 
